-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Entrepreneurial Delegation on the “Cangzhou Affection—Hometown Tour” Praises the Development of Guangxiang Pharmaceutical under Shisiyao Group
Category:
发布时间：2021-09-22
【概要描述】
On September 19, 130 representatives of provincial and national chambers of commerce and business leaders attending the inaugural “Cangzhou Affection—Hometown Visit” Entrepreneurs’ Mid-Autumn Fellowship and Cangzhou Investment Environment Promotion Conference visited Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisiyao Group in the Bohai New Area of Cangzhou for an inspection tour.
On September 19, 130 representatives of provincial and national chambers of commerce and business leaders attending the inaugural “Cangzhou Affection—Hometown Visit” Entrepreneurs’ Mid-Autumn Gala and Cangzhou Investment Environment Promotion Conference visited Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisiyao Group in the Cangzhou Bohai New Area for an inspection. Yin Weijiang, Vice Mayor of Cangzhou City, and Yu Zengzhou, Deputy Director of the Management Committee of the Cangzhou Bohai New Area, accompanied the delegation during the visit.
Members of the inspection delegation listened with great interest to a briefing on Shisiyao Group’s innovation initiatives and business development at Guangxiang Pharmaceutical Co., Ltd. in the Bohai New Area, and expressed sincere admiration for the Group’s achievements in seizing the opportunities presented by the coordinated development of the Beijing–Tianjin–Hebei region and accelerating its drive toward innovative, green, and high-quality growth. The delegation noted that Shisiyao Group’s persistent efforts and proven experience in advancing corporate transformation and upgrading are highly instructive and worthy of emulation by the business community.
Members of the inspection delegation unanimously stated that Cangzhou Bohai New Area enjoys high-level attention from both the provincial and municipal governments, benefits from a prime coastal location, and boasts cutting-edge technologies in the field of green development. What was once a saline-alkali wasteland has now been transformed into an attractive investment destination, and with the support of major strategic opportunities as well as national-level parks and bases, it holds enormous potential for future growth.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091